Skip to main content
Year archive

Bio Solution Co.,Ltd. — 2022 filings

All 24 regulatory filings released by Bio Solution Co.,Ltd. (086820) in 2022, sourced directly from the official regulator.

24 Filings
2022 Period
2022 filings (24)
Filing Released Lang
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
단일판매ㆍ공급계약해지
Regulatory Filings
2022-10-04 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
기타경영사항(자율공시)("유산균 유래 세포 외 소포체를 포함하는 항노화용 조성물" 특허권 취득)
Regulatory Filings
2022-08-04 Korean
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Regulatory Filings
2022-06-30 Korean
조회공시요구(현저한시황변동)
Regulatory Filings
2022-06-29 Korean
[기재정정]분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-17 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-30 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-22 Korean
사업보고서 (2021.12)
Annual Report FY 2021
2022-03-22 Korean
기타경영사항(자율공시)(특허권 취득)
Regulatory Filings
2022-03-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-03-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-14 Korean
주주총회집중일개최사유신고
AGM Information
2022-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-14 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2022-03-10 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-03-10 Korean
전환가액의조정(제1회차)
Share Issue/Capital Change
2022-02-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-11 Korean
전환가액의조정(제1회차 CB)
Capital/Financing Update
2022-01-13 Korean
배당락
Notice of Dividend Amount
2022-01-12 Korean
본점소재지변경
Regulatory Filings
2022-01-04 Korean